Real-world evidence of Besponsa in Belgium in acute lymphoblastic leukemia patients according to the prevailing reimbursement criteria Last updated: 2023-05-25 18:01
A study to examine the value of broad NGS panel testing when applied after reimbursed organ-directed NGS: a Belgian Precision study of the BSMO in collaboration with the Cancer Centre Last updated: 2022-10-18 17:30